Research programme: anti-estrogen compounds - AVAX TechnologiesAlternative Names: 6-MCDF; Alkyl-PCDFs research programme - AVAX Technologies; Anti-estrogen technologies research programme - AVAX Technologies; Polychlorodibenzofurans research programme - AVAX Technologies
Latest Information Update: 16 Mar 2007
At a glance
- Originator Texas A&M University
- Developer AVAX Technologies; Texas A&M University
- Mechanism of Action Estrogen receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer